China’s Xi speaks with Trump by phone, discusses Taiwan and bilateral ties
Grigorios Siokas, Chief Executive Officer of Cosmos Health Inc (NASDAQ: COSM), acquired 51,315 shares of the company’s common stock on November 20, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The transaction comes just one day before the company’s scheduled earnings release on November 21, with InvestingPro data showing analysts expect Cosmos to turn profitable this fiscal year despite not being profitable over the last twelve months.
The shares were purchased at a price of $0.6236 per share, for a total transaction value of $32,000. The filing indicates that these shares were acquired as an exchange for debt the company owed to Mr. Siokas, pursuant to a debt exchange agreement. This transaction occurs as the company operates with a significant debt burden of $21.07 million and a debt-to-equity ratio of 0.91. Following the transaction, Siokas directly owns 6,271,813 shares of Cosmos Health Inc, representing a substantial stake in the $19.29 million market cap company that InvestingPro analysis suggests is currently undervalued compared to its Fair Value.
In other recent news, Cosmos Health Inc. reported record financial results for the third quarter ending September 30, 2025, with revenue increasing by 38% to $17.11 million compared to the same period last year. The company also achieved its highest quarterly gross profit in history at $2.60 million, marking a 116% increase from the previous year. Additionally, Cosmos Health announced the launch of a new research and development program utilizing nanotechnology to enhance dietary supplements. This initiative builds on their existing technology developed for bioactive delivery. Furthermore, Cosmos Health has been actively investing in Ethereum, with their latest purchase of $200,000 bringing their total investment in the cryptocurrency to $2 million. This acquisition is part of their strategy to diversify their portfolio through digital assets. The company has been executing these purchases under a $300 million digital assets facility. These developments reflect Cosmos Health’s ongoing efforts to expand its operations and explore new technological advancements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.